). The RNA-binding properties of this protein were analyzed in an immunoprecipitation assay with the 100K-specific monoclonal antibody 2100K-1 (C. L. Cepko and P. A. Sharp, Virology 129:137-154, 1983 
Selective translation of viral late mRNAs occurs at late times after adenovirus infection of permissive cells (for reviews, see references 23, 37, and 50). The mechanisms that lead to efficient translation of viral mRNA but inhibition of cellular protein synthesis have not been fully elucidated. However, suppression of cellular translation requires progression into the late phase (26) , and neither the stability nor the in vitro translatability of cellular mRNAs is decreased (6, 56) . Three virus-encoded functions, VAl RNA, the tripartite leader sequence, and the L4 100-kDa nonstructural protein (100K protein), have been shown to increase translational efficiency during the late phase of infection. These viral activators of translation may also be involved in translational discrimination between viral late and cellular mRNAs.
Adenovirus VAl RNA is a small RNA polymerase III transcript required for the continued initiation of translation during the late phase (37, 39, 49, 56) . Following infection by a variety of viruses, an interferon-induced kinase, termed DAI or EIF-2a kinase, inhibits translation by phosphorylating the a subunit of the initiation factor EIF-2 (45) . The major role of VAl RNA is believed to be to counter this host antiviral response, by preventing activation of EIF-2a kinase. In cells infected by d1331, an adenovirus mutant that fails to synthesize VAl RNA, both cellular and viral protein synthesis is drastically reduced because of a lack of functional EIF-2 (49) . It between viral and cellular mRNAs, for in many adenovirusinfected cell lines, host mRNA translation is inhibited without measurable activation of EIF-2a kinase. Furthermore, the drug 2-aminopurine prevents inhibition of host mRNA translation without altering EIF-2ao kinase activity (30) .
The tripartite leader is a 202-nucleotide, 5' untranslated sequence common to most viral late mRNAs, those transcribed from the major late promoter. The leader increases translation of heterologous mRNAs during the late, but not the early, phase of infection and does not increase translational efficiency when placed at the 3' end of mRNA, suggesting a role in initiation (2, 11, 33, 35) . It has been proposed that the tripartite leader might reduce or eliminate the requirement for the cap-binding EIF-4F complex (20) . Since adenovirus infection results in underphosphorylation of cap-binding protein EIF-4E (31) and inactivation of the EIF-4F complex, such independence from EIF-4F activity could be important for discrimination of adenovirus late mRNAs from cellular mRNAs.
We have shown that the adenovirus L4 100K protein is required for efficient translation of late but not early viral mRNA species (29) . This protein, which is not found in mature virions, is synthesized in large quantities from the beginning of the late phase of infection (10) and is a major viral phosphoprotein (5, 24, 47) . The mechanism of action of the 100K protein is presently unknown. However, the protein binds to RNA in vivo (1) and appears to be associated with polyribosomal viral RNA or ribosomes (34, 52, 55, 58) . Therefore, we have investigated the specificity with which the 100K protein binds to RNA and compared in vitro RNA-binding activity with in vivo function, using a temperature-sensitive adenovirus L4 mutant, HStsl (60) . To investigate the specificity with which the lOOK protein binds to RNA, coprecipitation of radiolabeled RNA bound to the 100K protein was analyzed by an immunoprecipitation assay with the 2100K-1 monoclonal antibody (16) . Such an immunoprecipitation assay permitted RNA bound to the lOOK protein in solution to be analyzed and quantitated without complications introduced by the activities of other RNA-binding proteins present in infected cell extracts. It also permitted the use of a nonuniform RNA probe consisting of a mixture of RNA species. This was important, because the identities of any specific RNA sequences that might be bound by the lOOK protein were not known. The assay was characterized by immunoprecipitating 35S-labeled, infected cell cytoplasmic proteins under conditions identical to those used for subsequent RNA-binding analyses. In Fig. 1 , cytoplasmic proteins are shown prior to (lane 1) and following (lane 2) immunoprecipitation with the monoclonal antibody 2100K-1, which recognizes the native 100K protein (16) . The only proteins immunoprecipitated were lOOK and late polypeptide II (hexon). It has been reported previously that the lOOK protein forms a complex with polypeptide II that can be immunoprecipitated by the 2100K-1 antibody (16) .
To examine binding of the lOOK protein to RNA, cytoplasmic extracts prepared from unlabeled infected 293 cells were incubated with [3H]uridine-labeled infected cell RNA and immunoprecipitated. RNA was recovered and quantitated by scintillation counting. When increasing amounts of cytoplasmic protein were added to a constant amount of RNA, the quantity of RNA bound increased linearly up to 50 ,ug of protein added. At higher protein concentrations, there was no further increase in bound RNA (Fig. 2) . The maximum amount of RNA bound was between 0.7 and 1% of that added. In control experiments, uninfected extracts were substituted for infected cell extracts in the RNA-binding assay. Because these extracts did not contain any lOOK protein, no RNA was recovered following immunoprecipitation with the 2100K-1 antibody (data not shown). Furthermore, when the ElA antibody M73 replaced the 2100K-1 antibody in RNA-binding assays with infected cell extracts, no bound RNA was recovered (data not shown). These results indicate that the RNA recovered following immunoprecipitation with antibody 2100K-1 was a result of lOOK protein binding and was not nonspecifically precipitated by antigen-antibody-protein A-Sepharose complexes.
The specificity with which the lOOK protein bound to RNA was analyzed by adding various unlabeled competitors to binding reaction mixtures that contained 3H-infected cell RNA. When the nucleic acid preference of the 100K protein was examined in this fashion, binding was found to be specific for single-stranded nucleic acids; a 50-fold excess of infected cell RNA or single-stranded DNA completely (100%) displaced 3H-infected cell RNA binding, whereas tRNA, double-stranded DNA, and double-stranded RNA were ineffective competitors (0% displacement of 3H-infected cell RNA). In this respect, the L4 class of cellular RNA-binding proteins exhibit strong preferences for specific ribohomopolymers. Poly(A)-binding proteins can, for example, be purified by virtue of their selective binding to poly(A) (8, 12) , the heteronuclear ribonucleoprotein (hnRNP) Cl and C2 proteins bind preferentially to poly(U), and hnRNPs K and J bind very tightly to poly(C) (8, 12, 38, 53) . Therefore, we employed the immunoprecipitation assay to determine whether the 100K protein bound preferentially to one or more ribohomopolymers. In these experiments, the efficiencies of binding to different RNAs were compared by competition assays in which increasing quantities of unlabeled RNA were added to binding reaction mixtures containing the 100K protein and 3H-labeled, Ad5-infected cell RNA. Neither poly(C) nor poly(A) inhibited binding of the protein to infected cell RNA, even when present at a concentration 2 orders of magnitude higher than that of the labeled RNA probe (Fig. 3) . By contrast, both poly(U) and poly(G) were effective inhibitors of the RNAbinding activity of the protein (Fig. 3) . This difference in ribohomopolymer binding specificity was reproducibly observed with different preparations of the 100K protein. Some differences in mean length and ranges of lengths were observed when the ribohomopolymers were examined by electrophoresis under denaturing conditions. However, these differences cannot account for the results shown in Fig. 3 ; the poly(A) and poly(U) populations were, for example, similar, yet only the latter was bound efficiently by the 100K protein.
The results shown in Fig. 3 indicate that the adenovirus L4 lOOK protein possesses strong preferences for some RNA sequences (rich in U or G) over others. However, they do not address the most important question raised by our previous in vivo experiments (29) , whether the 100K protein selectively recognizes viral late mRNA species. Therefore, we next compared the binding of the protein to cytoplasmic, poly(A)-containing and poly(A)-lacking RNAs prepared from both uninfected and Ad5-infected cells using the competition assay. Binding of the lOOK protein to 3H-infected cell RNA was decreased by addition of the unlabeled, homologous RNA and was completely inhibited by addition of a 10-fold (mass) excess of competitor (Fig. 4) . However, no differences between poly(A)-containing and poly(A)-lacking RNA preparations or between uninfected and AdSinfected cell RNA preparations as inhibitors of lOOK binding to infected cell RNA could be discerned (Fig. 4) .
Adenovirus infection induces inhibition of appearance in the cytoplasm of newly synthesized cellular mRNA and 28S rRNA (10, 15) . Thus, most of the RNA labeled in infected cells between 18 and 22 h after infection used in these experiments should be viral in origin, particularly in the poly(A)-containing fraction. However, we wished to determine whether any specificity in the interaction of the lOOK protein with RNA could be discerned when the protein was provided with a population of RNA molecules that was exclusively viral in origin. Therefore, we used SP6 RNA polymerase to transcribe a construct in which sequences encoding the 202-nucleotide tripartite leader upstream from an L2 mRNA for the 11-kDa precursor to virion protein ,u (3) were placed downstream of the phage promoter. This approach also permitted comparison of capped and uncapped mRNAs as substrates for the lOOK protein, a comparison that seemed particularly pertinent in view of the preference for G described previously. The results of these experiments were similar to those obtained when the specificity of lOOK protein-RNA binding was examined with 3H-infected cell RNA as probe; there was no difference in the displacement of 32P-labeled L2 mRNA by capped or uncapped, unlabeled, synthetic L2 RNAs, and both uninfected and infected cell RNAs were effective inhibitors of the binding reaction (data not shown). Cellular RNA-binding proteins present in the lOOK protein-containing cytoplasmic extracts of AdS-infected cells do not register in the immunoprecipitation assay for the RNA-binding activity of the viral protein, as described previously. Nevertheless, it seemed possible that such cellular proteins interfered with our ability to detect preferences of the lOOK protein for a particular class of infected cell RNA. Therefore, the lOOK protein was purified by extraction of the pellet recovered upon centrifugation of cytoplasmic extracts at 100,000 x g for 1 h with 0.5 M NaCl. Analysis of the polypeptide compositions of such fractions by Coomassie blue staining of SDS-polyacrylamide gels established that the 100K protein constituted 10 to 20% of the total and was the most abundant polypeptide recovered, by a factor of 3 to 4 (data not shown). Nevertheless, no preference for viral poly(A)-containing RNA could be detected when such 100K protein preparations were used in competition experiments like those shown in Fig. 4 .
In vitro RNA-binding activity of mutant and wild-type adenovirus lOOK proteins correlates with in vivo translational efficiency. The ability of the 100K protein to bind to poly(U) (Fig. 3) (29) . Total cell proteins (Fig. 7, lanes 2 and  3) prepared from wild-type-and mutant-infected cells at the permissive temperature (33°C) were incubated with poly(U) RNA immobilized on Sepharose. Two major labeled proteins were eluted from the poly(U)-Sepharose (Fig. 5, lanes  1 and 2) . The identities of these two proteins as the lOOK protein and late polypeptide II were confirmed by eluting the poly(U)-Sepharose with 0.3 M NaCl in RBB and immunoprecipitating the eluted proteins with the 100K proteinspecific antibody 2100K-1 (Fig. 5, lanes 5 and 6) . To determine whether the abundant polypeptide II was present in these RNA eluates by virtue of its association with the lOOK protein or as a result of direct RNA binding, protein eluates were rebound and eluted from the poly(U)-Sepharose (Fig.  5, lanes 3 and 4) . Polypeptide II was present after two rounds of poly(U) selection, indicating that it is unlikely to be nonspecifically trapped by the poly(U)-Sepharose; it is probably bound to the RNA as a result of its interaction with the 100K protein. The (Fig. 7, lanes 2 and 3) . The lOOK protein present in extracts prepared from AdS-infected cells maintained at the permissive temperature bound well to poly(U)-Sepharose at both 33 and 39°C (Fig. 6, lanes 1, 4, 5 , and 6). By contrast, binding of the lOOK protein prepared from H5tsl-infected cells was significantly less at 39°C than at 33°C (Fig. 6, compare lanes 7 and 8 with lanes 2 and 3) . Quantitation of the results shown in Fig. 6 and of those from similar experiments with independent preparations of the 100K proteins (Table 1) established that the RNA-binding activity of the wild-type protein was decreased by no more than 1.6-fold at 39°C. By contrast, when incubated at 39°C, H5tsl 100K protein prepared at low temperature exhibited a 3.7-to 4.4-fold decrease in RNA-binding activity ( Table 1) .
The decreased ability of the H5tsl 100K protein to bind to RNA at 39°C could be the direct result of its temperaturedependent loss of RNA-binding activity or a trivial result of the increased instability of the mutant protein at high temperature. To investigate the latter possibility, we compared the temperature sensitivities of the interactions of the wildtype and mutant 100K proteins with 2100K-1 antibody. No difference between the binding activities of the wild-type and H5tsl mutant proteins to the antibody was observed; similar quantities of the wild-type and mutant 100K polypeptides were recovered following immunoprecipitation of infected cell extracts at 4, 22, or 33°C (Fig. 7, lanes 4 to 12) . In both cases, moreover, incubation at 39°C resulted in a decrease in the quantity of 100K protein immunoprecipitated (Fig. 7,  lanes 13 to 15) proteins were immunoprecipitated (Fig. 7, lanes 4, 7, 10 , and 13).
DISCUSSION
Adenovirus infection alters the translational machinery of cells permissive for its replication, impairing the activity of at least two initiation factors. Although the virus-encoded RNA, VAl RNA, partially circumvents the phosphorylation of the ax subunit of EIF-2 and concomitant inactivation of this factor resulting from activation of EIF-2 kinase (see the introduction), the degree of phosphorylation that can be attained even in the presence of VAl RNA is characteristic of complete inhibition of translation in other systems (39) . In addition, EIF-4F (cap-binding complex) is inactivated following adenovirus infection (31) . Thus, by the late phase of infection, essential components of the cellular translational initiation machinery are functionally impaired. Despite such a translationally compromised environment, viral late mRNA species continue to be translated for many hours. Because cellular mRNAs are present in infected cells throughout this period and are translatable in vitro (6, 56) , it is clear that a mechanism must exist to ensure translation of a specific subset of the mRNAs present in the cytoplasm of cells that have entered the late phase of infection. The tripartite leader common to the spliced products of the major late transcription unit appears to play an important role in such selection, for it alleviates the requirement for the cap-binding complex (20) . However, viral mRNAs expressed from other transcription units, including the IVa2 and pIX mRNAs and certain mRNA products of early transcription units, which lack the tripartite leader or 5' untranslated sequences related to it, are also translationally active during this period (29) .
Translation of all adenovirus late mRNAs, but not of early mRNA species, requires the L4 100K nonstructural protein (29) . Since the 100K protein plays no role in inhibition of cellular protein synthesis (29) , its primary function appears to be to facilitate translation of late mRNAs in the translationally compromised environment characteristic of adenovirus-infected cells. The ability of the 100K protein to bind to RNA in vivo (1) and the sequences (24, 29, 34) and phenotypic properties of H5tsl and a set of its revertants led us to suggest that the translational function of this adenovirus protein depended in some way on its RNA-binding activity (29) . The results presented here provide the first experimental support for this hypothesis. A temperature-dependent decrease in RNA-binding activity was observed in vitro ( Fig.  6 ; Table 1 ) when the lOOK protein was prepared (at low temperature) from cells infected by H5tsl, a virus temperature sensitive for growth because of a single amino acid substitution in the 100K coding sequence (29) . By contrast, when the binding activities of the wild-type 100K protein to RNA at 33 and 39°C were compared, little effect of temperature was detected. Because the mutant and wild-type proteins exhibit identical, temperature-dependent changes in their interactions with the 2100K-1 antibody (Fig. 7) , the failure of the mutant protein to bind to RNA efficiently at 39°C ( Fig. 6 ; Table 1 ) can be ascribed to a direct effect of the mutation rather than an indirect effect resulting from changes in protein stability. Thus, the in vitro temperature sensitivity of H5ts1 100K protein RNA-binding activity correlates with in vivo translational efficiency; both the in vitro RNA-binding activity of the mutant protein and in vivo translational efficiency are lower at the nonpermissive temperature (39°C) than at the permissive temperature (33°C).
The wild-type and the mutant 100K proteins undergo a common conformational change in vitro when the temperature is raised from 33 to 39°C that results in loss of recognition of the 2100K-1 epitope (Fig. 7) , but neither the in vivo translational function nor the in vitro RNA-binding activity of the wild-type protein is significantly impaired at 39°C (29) ( Fig. 6; Table 1 ). Therefore, it appears that some aspect of the conformation of the wild-type protein is intrinsically sensitive to temperature and that an independent, temperature-sensitive change resulting from replacement of serine 466 by proline in the H5tsl lOOK protein (29) leads to loss of translational function in vivo (29) and to reduced RNAbinding activity in vitro. In vivo, little recovery from the inhibitory effects of the H5ts1 mutation is observed in the first few hours following a shift from a nonpermissive to a permissive temperature (28a), suggesting that this conformational change is irreversible.
In view of the properties of translation during the late phase of adenovirus infection discussed previously, the most obvious function for the RNA-binding activity of the 100K protein would be in direct selection of late mRNAs for efficient translation. Viral or cellular proteins that control the translation of specific mRNA species have been previously identified and characterized and in some cases have been shown to be sequence-specific RNA-binding proteins (9, 44) .
The Rev protein of the human immunodeficiency virus (HIV) and the cellular iron-responsive element (IRE) binding protein, for example, interact specifically with cis-acting RNA elements, the Rev-response element (RRE) and IRE, respectively, that contain stem-loop structures (4, 19, 27, 36, 46) . Interaction of the IRE binding protein with an IRE in the 5' untranslated region of ferritin mRNA suppresses translation (46) , whereas binding of Rev to RREs present in unspliced and partially spliced HIV mRNAs facilitates their assembly into polyribosomes and translation (4, 19) . Although the adenovirus lOOK protein, like Rev, increases polysome loading and translation of a specific set of mRNA species (29) , it exhibited no preference for binding to viral mRNAs in our in vitro assays (e.g., Fig. 4 (1) , as it does in our in vitro assays. Therefore, it seems unlikely that the specificity with which the lOOK protein increases translational efficiency in adenovirus-infected cells (21) is the result of specific binding of this protein to viral late mRNAs.
We have previously reported (29) that of the H5tsl lOOK and H5ts2 hexon mutations, only the former induces a significant translational defect under nonpermissive conditions, despite their similar phenotypes with respect to hexon morphogenesis (16) . Therefore, the translational function of the lOOK protein appears to be independent of its role in hexon trimerization, which is presumed to be mediated by interaction with nascent hexon polypeptide chains (e.g., see references 16, 25, and 40 (Fig. 3) (17, 51) . Therefore, it seems reasonable to suppose that the ribohomopolymer preference exhibited by the adenoviral 100K protein in vitro is related to its in vivo function. However, a function for the lOOK protein in RNA processing analogous to that of the RNP C proteins seems unlikely; cells infected by H5tsl at a nonpermissive temperature display no discernible defects in the production of viral mRNA species (29) . Moreover, unlike the cellular RNP C proteins (53), the AdS 100K protein does not bind poly(U) efficiently at high salt concentrations (Fig. 5) .
It is possible that the RNA-binding activity of the LA lOOK protein is related to the mechanism (presently unknown) whereby the protein facilitates translation. If this were the case, the lOOK protein could be considered a general translational activator, the specificity observed in vivo being conferred by other components. Such components would include the tripartite leader, which renders translation of mRNAs to which it is linked independent of EIF-4F (20) , and VAl RNA, which has been proposed to confer local protection against inactivation of EIF-2a in the vicinity of viral late mRNA species and thus ensure the continued translation of this class (39 (29) , and the selective export of viral mRNAs during the late phase of infection requires early E1B and E4 proteins (7, 14, 18, 41, 61 
